Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection
Authors
Keywords
-
Journal
CELL RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-11
DOI
10.1038/s41422-019-0153-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Kinase activity of mutant LRRK2 manifests differently in hetero-dimeric vs homo-dimeric complexes
- (2019) Emmanouela Leandrou et al. BIOCHEMICAL JOURNAL
- Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease
- (2018) Chadwick W. Christine et al. MOVEMENT DISORDERS
- Functional variants in the LRRK2 gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease
- (2018) Ken Y. Hui et al. Science Translational Medicine
- Vitamin B12 deficiency
- (2017) Ralph Green et al. Nature Reviews Disease Primers
- Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors
- (2016) G. Ito et al. BIOCHEMICAL JOURNAL
- G2019S-LRRK2 Expression Augments -Synuclein Sequestration into Inclusions in Neurons
- (2016) L. A. Volpicelli-Daley et al. JOURNAL OF NEUROSCIENCE
- Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease
- (2016) Kyle B. Fraser et al. MOVEMENT DISORDERS
- Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019SLRRK2carriers
- (2016) Kyle B. Fraser et al. NEUROLOGY
- Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations
- (2016) Katerina Melachroinou et al. PLoS One
- Structural model of the dimeric Parkinson’s protein LRRK2 reveals a compact architecture involving distant interdomain contacts
- (2016) Giambattista Guaitoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacological LRRK2 kinase inhibition induces LRRK2 protein destabilization and proteasomal degradation
- (2016) E. Lobbestael et al. Scientific Reports
- LRRK2 dephosphorylation increases its ubiquitination
- (2015) Jing Zhao et al. BIOCHEMICAL JOURNAL
- Homocysteine excess: delineating the possible mechanism of neurotoxicity and depression
- (2015) Pankaj Bhatia et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
- (2015) João P. L. Daher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Characterization of LRRK2 Inhibitors
- (2015) Bernd K. Gilsbach et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Parkinson's Disease-Associated Mutation LRRK2-G2019S Impairs Synaptic Plasticity in Mouse Hippocampus
- (2015) E. S. Sweet et al. JOURNAL OF NEUROSCIENCE
- Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
- (2015) M. Yue et al. NEUROBIOLOGY OF DISEASE
- Associations between B Vitamins and Parkinson’s Disease
- (2015) Liang Shen Nutrients
- Abnormal visual gain control in a Parkinson's disease model
- (2014) F. Afsari et al. HUMAN MOLECULAR GENETICS
- Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor
- (2014) Jaclyn L. Henderson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mutant LRRK2 Toxicity in Neurons Depends on LRRK2 Levels and Synuclein But Not Kinase Activity or Inclusion Bodies
- (2014) G. Skibinski et al. JOURNAL OF NEUROSCIENCE
- Dopaminergic expression of the Parkinsonian gene LRRK2-G2019S leads to non-autonomous visual neurodegeneration, accelerated by increased neural demands for energy
- (2013) Samantha Hindle et al. HUMAN MOLECULAR GENETICS
- Binding Interactions of β-Conglycinin and Glycinin with Vitamin B12
- (2013) Jing Zhang et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs
- (2013) Marco A. S. Baptista et al. PLoS One
- GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor
- (2012) Alastair D. Reith et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Characterization of TAE684 as a potent LRRK2 kinase inhibitor
- (2012) Jinwei Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity
- (2012) C. Yao et al. HUMAN MOLECULAR GENETICS
- ArfGAP1 Is a GTPase Activating Protein for LRRK2: Reciprocal Regulation of ArfGAP1 by LRRK2
- (2012) Y. Xiong et al. JOURNAL OF NEUROSCIENCE
- Retinal Dopamine Mediates Multiple Dimensions of Light-Adapted Vision
- (2012) C. R. Jackson et al. JOURNAL OF NEUROSCIENCE
- Roco kinase structures give insights into the mechanism of Parkinson disease-related leucine-rich-repeat kinase 2 mutations
- (2012) B. K. Gilsbach et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
- (2012) Z. Sheng et al. Science Translational Medicine
- Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database
- (2012) Christina M. Lill et al. PLoS Genetics
- Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson’s Disease-Related Toxicity in Human Neurons
- (2011) Nigel Ramsden et al. ACS Chemical Biology
- The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling
- (2011) Arvin C. Dar et al. Annual Review of Biochemistry
- Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
- (2011) Zhaohui Liu et al. HUMAN MOLECULAR GENETICS
- Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
- (2011) Xianming Deng et al. Nature Chemical Biology
- Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson’s disease
- (2011) Soraya Bardien et al. PARKINSONISM & RELATED DISORDERS
- Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease
- (2011) Chuong B. Do et al. PLoS Genetics
- Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease
- (2010) Cory Toth et al. ANNALS OF NEUROLOGY
- Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
- (2010) Nicolas Dzamko et al. BIOCHEMICAL JOURNAL
- Membrane Localization of LRRK2 Is Associated with Increased Formation of the Highly Active LRRK2 Dimer and Changes in Its Phosphorylation
- (2010) Zdenek Berger et al. BIOCHEMISTRY
- LRRK2 G2019S in the North African Population: A Review
- (2010) Hani T.S. Benamer et al. EUROPEAN NEUROLOGY
- Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S
- (2010) X. Li et al. JOURNAL OF NEUROSCIENCE
- Vitamin B12: Unique Metalorganic Compounds and the Most Complex Vitamins
- (2010) Lucio Randaccio et al. MOLECULES
- Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
- (2010) Byoung Dae Lee et al. NATURE MEDICINE
- LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease
- (2010) Chen Yao et al. NEUROBIOLOGY OF DISEASE
- Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
- (2010) H.L. Melrose et al. NEUROBIOLOGY OF DISEASE
- Protein-binding assays in biological liquids using microscale thermophoresis
- (2010) Christoph J. Wienken et al. Nature Communications
- Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
- (2009) R. Jeremy Nichols et al. BIOCHEMICAL JOURNAL
- The tinker, tailor, soldier in intracellular B12 trafficking
- (2009) Ruma Banerjee et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Inhibition of nitric oxide synthase by cobalamins and cobinamides
- (2009) J. Brice Weinberg et al. FREE RADICAL BIOLOGY AND MEDICINE
- Dependence of Leucine-rich Repeat Kinase 2 (LRRK2) Kinase Activity on Dimerization
- (2009) Saurabh Sen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration
- (2009) C. C.-Y. Ho et al. JOURNAL OF NEUROSCIENCE
- LRRK2 Modulates Vulnerability to Mitochondrial Dysfunction in Caenorhabditis elegans
- (2009) S. Saha et al. JOURNAL OF NEUROSCIENCE
- Parkinson's disease
- (2009) Andrew J Lees et al. LANCET
- Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
- (2009) Wataru Satake et al. NATURE GENETICS
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Mutant LRRK2 R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
- (2009) Yanping Li et al. NATURE NEUROSCIENCE
- Neuropathology of non-motor features of Parkinson disease
- (2009) Dennis W. Dickson et al. PARKINSONISM & RELATED DISORDERS
- R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
- (2009) Y. Tong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
- (2008) Yuzuru Imai et al. EMBO JOURNAL
- Investigation of leucine-rich repeat kinase 2
- (2008) Vasanti S. Anand et al. FEBS Journal
- The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation
- (2008) Elisa Greggio et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protein−Protein Interaction Detection in Vitro and in Cells by Proximity Biotinylation
- (2008) Marta Fernández-Suárez et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- A Drosophila model for LRRK2-linked parkinsonism
- (2008) Z. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Folate and vitamin B12 levels in levodopa-treated Parkinson's disease patients: Their relationship to clinical manifestations, mood and cognition
- (2007) Nikolaos I. Triantafyllou et al. PARKINSONISM & RELATED DISORDERS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started